Recursion Pharmaceuticals, Inc.
RXRX
Jodie situation report
Recursion Pharmaceuticals, Inc.'s move is spreading beyond its market group.
No new filing conclusion is available. 5 of 8 group members are active now; 1 filing-linked outsider is moving with the group, and 0 of 11 directly disclosed connections are confirming.
- Participation spreads to CLNN, PACB, VERU.
- Capital-flow agreement rises above 55%.
- TXG remains aligned with the group in the next market snapshot.
Invalidation: The live read weakens if participation falls to 2 of 8 members or fewer.
Who this business touches
The relationships behind RXRX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
MRKMerck & Company, Inc.partnerMay 6, 2026 ▾
“Merck KGaA, Darmstadt, Germany Research Collaboration Agreement In September 2023, we entered into a Research Collaboration Agreement, or the RCA, with the Healthcare Business of Merck KGaA, Darmstadt, Germany, referred to as Merck KGaA, Darmstadt, Germany, p…”
SNYSanofipartnerMay 6, 2026 ▾
“In AI-enabled chemistry, Sanofi and Recursion joint programs continue progressing toward development candidate designation and earlier-stage milestones over the next 12 months, including programs designed against challenging targets in immunology and oncology.”
Depended on by
RLYBRallybio CorporationinvesteeMar 16, 2026 ▾
“In July 2025, the Company entered into a definitive agreement to sell its interest in REV102, an Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 ("ENPP1") inhibitor in preclinical development for the treatment of patients with hypophosphatasia ("HPP"), to…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 12 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
RXRX is currently a Early Follower in the organic co-movement group Gene Therapies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.